Skip to content
  • Portfolio
  • News
  • About
  • Team
  • Funds
  • Portfolio
  • News
  • About
  • Team
  • Funds
Contact

Topic: New venture

Enabling technology for lightweight structures and materials: the story of Eddytec

Amplio Pharma B.V. recently completed a second closing within their Seed Investment Round in support of the clinical development of NovoBioJect for the treatment of rheumatoid arthritis

‘Invest International’ invests in Plantics to accelerate international scale up

InspectT receives convertible loan from Innovatiefonds Noord-Holland

AviSia Therapeutics receives convertible loan from Innovatiefonds Noord-Holland

First babies in the Netherlands protected against RSV by Amsterdam UMC invention

Amplio Pharma receives EMA approval for Phase 1b trial in patients with rheumatoid arthritis

XO Ventures and CbusineZ invest €1.35 million in TrianecT to accelerate stroke detection in ambulances

ICOS Capital invests in Plantics B.V. to accelerate scale up

Quantum-centric workflows for predicting RNA secondary structure

Next →
Holdings of our founding institutes
  • Amsterdam UMC Ventures Holding
  • HvA Ventures Holding
  • UvA Ventures Holding
  • Amsterdam UMC Ventures Holding
  • HvA Ventures Holding
  • UvA Ventures Holding
Contact

Amsterdam Academic Ventures 

Roetersstraat 35

1018 WB Amsterdam

020 2466100

info@aav.nl

© 2026 Amsterdam Academic Ventures

  • Disclaimer
  • Privacy Statement
  • Disclaimer
  • Privacy Statement
  • Portfolio
  • News
  • About
  • Team
  • Funds
  • Portfolio
  • News
  • About
  • Team
  • Funds
Contact